Testgene - About us

About us

TestGene is one of the leading R&D companies in the Russian market of molecular diagnostics, biotechnology and bioinformatics.

We are focused on developing fundamentally new products and promoting advanced technologies in the field of molecular diagnostics.

Our solutions are used by specialists in laboratory diagnostics in Russia, the CIS countries and the world.

In 10 years we have produced 10 million tests for laboratory diagnostics, including 300,000 tests for diagnostics in oncology.

5

R&D - laboratories

5

production sites

ISO-13485

>60

products in our portfolio

R&D

Our desire to create innovative diagnostic systems has united international developers. Now our development team consists of three research groups in Moscow, Novosibirsk and Ulyanovsk. “TestGene” employs many researchers with PhD in Medical and Biological Sciences, who conduct scientific, research and teaching activities and have hundreds of scientific publications.

More

Company’s timeline

2012

TestGene is founded

Development of a reagent kit for prenatal diagnostics.

2014

Development of reagent kits for cancer diagnostics.

2018

Prenatal screening using a test system "TestGene" is implemented in the regions of Russia.

2019

Approximately 50% of test for determining the targeted therapy are performed on a TestGene reagent kit.

2020

A reagent kit for diagnosing infections is developed.
The R&D site in Novosibirsk is opened.

2021

We started production of rapid tests.
The R&D site in Moscow is opened.
A reagent kit is developed on the basis of NGS and LAMP technologies.

2022

A production site in Moscow is opened.
We are preparing to producefreeze-dried kits.
Our portfolio has over 50 products.

Production

Learn more